PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)

被引：0
|
作者：
KANTARJIAN, H [1 ]
SMITH, T [1 ]
OBRIEN, S [1 ]
ROBERTSON, L [1 ]
KOLLER, C [1 ]
BERAN, M [1 ]
KEATING, M [1 ]
TALPAZ, M [1 ]
机构：
[1] MD ANDERSON CANC CTR,HOUSTON,TX
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A378 / A378
页数：1
相关论文
共 50 条
  • [31] Treatment of patients with multiply myeloma (MM) and chronic myelogenous leukemia (CML) with alpha-2 interferon (IFN).
    Bessmeltsev, SS
    Rukavitsyn, OA
    Abdulkadyrov, KM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 711 - 711
  • [32] A RETROSPECTIVE STUDY OF PROGNOSTIC FACTORS AT DIAGNOSIS IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    ZALOZNIK, AJ
    DIBELLA, NJ
    BOURG, WC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 478 - 478
  • [33] ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT)
    HIGANO, C
    RASKIND, W
    FLOWERS, M
    BLOOD, 1993, 82 (10) : A169 - A169
  • [34] Autologous stem cell transplantation (ASCT) for patients with chronic myeloid leukemia (CML) in first chronic phase (CP1) not responding to alpha-interferon (IFN).
    Boiron, JM
    Cahn, JY
    CarloStella, C
    Bandini, G
    Meloni, G
    Reman, O
    Carreras, E
    Michallet, M
    DeLaurenzi, A
    Milpied, N
    Granena, A
    Faberes, C
    Apperley, J
    Reiffers, J
    BLOOD, 1996, 88 (10) : 492 - 492
  • [35] RESULTS OF RECOMBINANT ALPHA-2-C-INTERFERON THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KUHRER, I
    LINKESCH, W
    LUDWIG, H
    GISSLINGER, H
    BLUT, 1987, 55 (04): : 390 - 390
  • [36] CHRONIC MYELOID-LEUKEMIA, BCR/ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL
    BACCARANI, M
    TURA, S
    RUSSO, D
    BACCARANI, M
    ZACCARIA, A
    SAGLIO, G
    GUERRASIO, A
    MARTINELLI, G
    ZUFFA, E
    TESTONI, N
    FARABEGOLI, P
    ZAMAGNI, MD
    FANIN, R
    DAMIANI, D
    DEMILIO, A
    BATTISTA, R
    SPECCHIA, G
    LISO, V
    DITUCCI, A
    BROCCIA, G
    MONTEFUSCO, E
    MANDELLI, F
    RAMBALDI, A
    BARBUI, T
    BODENIZZA, CA
    CAROTENUTO, M
    ROTONDO, SG
    AMBROSETTI, A
    PERONA, G
    LUCIANO, L
    ROTOLI, B
    RONCO, F
    NOBILE, F
    TABILIO, A
    LIBERATI, A
    MARTELLI, M
    GRIGNANI, F
    PARDINI, S
    LONGINOTTI, M
    GENTILINI, I
    COSER, P
    LEONI, F
    CIOLLI, S
    MORRA, E
    BERNASCONI, C
    FERRERO, D
    PILERI, A
    LEONI, P
    DANIELI, G
    ABBADESSA, A
    LEUKEMIA, 1995, 9 (10) : 1648 - 1652
  • [37] Sudden elastic phase (SBP) transformation in the first 2 years (yrs) of interferon-α (IFN) therapy (RX) for chronic phase (CP) chronic myelogenous leukemia (CML).
    Thomas, D
    Kantarjian, H
    O'Brien, S
    Cortes, J
    Giles, FJ
    Faderl, S
    Rios, M
    Keating, M
    Talpaz, M
    BLOOD, 1998, 92 (10) : 251A - 251A
  • [38] NATURAL-KILLER-CELL ACTIVITY AND CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH ALPHA-INTERFERON
    MESERI, A
    DELWAIL, V
    MAHON, FX
    PELLETIER, D
    GUILHOT, F
    BRIZARD, A
    GOMBERT, J
    TANZER, J
    DELAFOREST, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (04) : 585 - 586
  • [39] THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON
    FULLE, HH
    DAHMEN, E
    HELLRIEGEL, KP
    ONKOLOGIE, 1988, 11 (04): : 177 - &
  • [40] THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON
    KURZROCK, R
    GUTTERMAN, JU
    KANTARJIAN, H
    TALPAZ, M
    CANCER INVESTIGATION, 1989, 7 (01) : 83 - 91
12345